A Systematic Review and Meta-Analysis on Microsurgical Safety and Efficacy of Profunda Artery Perforator Flap in Breast Reconstruction

医学 乳房再造术 血清瘤 外科 血肿 荟萃分析 伤口裂开 裂开 乳房整形术 置信区间 并发症 乳房切除术 乳腺癌 内科学 癌症
作者
Bei Qian,Lingyun Xiong,Jialun Li,Ying Sun,Jiaming Sun,Nengqiang Guo,Zhenxing Wang
出处
期刊:Journal of Oncology [Hindawi Limited]
卷期号:2019: 1-12 被引量:24
标识
DOI:10.1155/2019/9506720
摘要

The profunda artery perforator (PAP) flap was first applied in breast reconstruction in 2010 by Robert J. Allen. It provided an alternative for autologous breast reconstruction in addition to traditional donor sites. Currently, literature reporting its microsurgical safety and efficacy is relatively sparse and heterogeneous. Objective. To clarify the evidence regarding microsurgical safety and efficacy of PAP flap in breast reconstruction, which may contribute to future surgical decision-making.Multiple databases were systematically searched by two independent reviewers. The result was statistically analyzed with Meta command of R GUI 3.5.1. The proportions with 95% confidence intervals (CIs) were calculated by using random-effect model.There were 12 studies including 516 PAP flaps meeting the inclusion criteria. The pooled surgical success rate was 99% (95% CI: 97%-100%) and overall rate of complications was 23% (95% CI: 18%-27%). The most common individual complication was wound dehiscence with incidence of 6% (95% CI: 4%-9%). The seroma rate was 2% (95%CI: 0%-6%). The hematoma rate was 1% (95% CI: 0%-2%). The partial necrosis rate was 2% (95% CI: 0%-5%). The rate of total flap loss was 1% (95% CI: 0%-3%).To date, this study is the first meta-analysis of microsurgical efficacy and safety evaluation of the PAP flap in breast reconstruction. This present work confirmed that the PAP flap is safe and reliable in breast reconstruction with high success rate, but a relatively low complication rate. Moreover, it might be more than an alternative to the deep inferior epigastric perforator flap (DIEP) in microsurgical breast reconstruction in selected patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
zoko发布了新的文献求助10
刚刚
刚刚
曾经的臻发布了新的文献求助10
刚刚
华仔应助S1mple_gentleman采纳,获得10
刚刚
科研通AI5应助CC采纳,获得10
刚刚
刚刚
1秒前
1秒前
张静静完成签到,获得积分10
2秒前
2秒前
震666发布了新的文献求助30
2秒前
MADKAI发布了新的文献求助10
2秒前
2秒前
117发布了新的文献求助10
2秒前
3秒前
3秒前
酶没美镁完成签到,获得积分10
3秒前
小二郎应助Rui采纳,获得10
3秒前
Libra完成签到,获得积分10
4秒前
雪儿发布了新的文献求助30
4秒前
无悔呀发布了新的文献求助10
4秒前
小巧的可仁完成签到 ,获得积分10
4秒前
4秒前
zhao完成签到,获得积分10
5秒前
masu发布了新的文献求助10
5秒前
冷酷尔琴发布了新的文献求助10
6秒前
Ll发布了新的文献求助10
6秒前
优雅山柏完成签到,获得积分10
6秒前
XinyiZhang发布了新的文献求助10
6秒前
小蘑菇应助yangyang采纳,获得10
6秒前
慕青应助欢欢采纳,获得10
7秒前
小憩完成签到,获得积分10
7秒前
南乔发布了新的文献求助10
7秒前
张静静发布了新的文献求助10
8秒前
云儿完成签到,获得积分10
8秒前
淡淡的洋葱完成签到,获得积分10
8秒前
小洲王先生完成签到,获得积分10
9秒前
9秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527521
求助须知:如何正确求助?哪些是违规求助? 3107606
关于积分的说明 9286171
捐赠科研通 2805329
什么是DOI,文献DOI怎么找? 1539901
邀请新用户注册赠送积分活动 716827
科研通“疑难数据库(出版商)”最低求助积分说明 709740